Company profile: California Nanotechnologies
1.1 - Company Overview
Company description
- Provider of nano-structured components and materials and research and development services, using metallic, ceramic, MMC, and MMNC materials for applications from aerospace to sports & recreation. Offerings include Spark Plasma Sintering (SPS) systems and modeling software, cryogenic milling, hot isostatic pressing (HIP) services, tungsten carbide tooling, and high-strength SPS graphite tooling.
Products and services
- Cryogenic Milling: Industrial-grade powder processing that reduces particle size and refines nano-grains at cryogenic temperatures, enhancing mechanical properties of metallic, ceramic, and composite materials for aerospace and sports applications
- Hot Isostatic Pressing (HIP) Services: Production-scale HIP applies high temperature and pressure simultaneously to consolidate materials, improving mechanical properties and integrity of advanced nano-structured components and materials
- Spark Plasma Sintering (SPS) Systems: Custom-engineered systems fabricate dense metallic, ceramic, MMC, and MMNC components from powders using pulsed direct current and uniaxial pressure for materials science and engineering
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to California Nanotechnologies
Bruker Alicona
HQ: Austria
Website
- Description: Provider of optical 3D surface measurement technology for quality assurance in laboratories and production. Offers optical 3D metrology and Focus-Variation technology for non-contact, high-resolution 3D measurements, bridging coordinate metrology and surface roughness measurement. Products include µCMM, InfiniteFocus G6, InfiniteFocusSL, and Real3DUnitX to measure dimensions, position, shape, and roughness of complex components.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bruker Alicona company profile →
Tacere Therapeutics
HQ: United States
Website
- Description: Provider of novel therapeutics for serious infectious diseases, including Hepatitis C (HCV), leveraging RNA interference (RNAi), gene medicine, and novel biologicals, with proprietary expertise in identifying and developing RNAi therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tacere Therapeutics company profile →
Obducat
HQ: Sweden
Website
- Description: Provider of micro- and nanolithography solutions, technologies, products and processes for advanced micro- and nanopatterning of surfaces, supporting the development of sensor devices, medical devices, and optical and photonic devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Obducat company profile →
Blueberry Therapeutics
HQ: United Kingdom
Website
- Description: Provider of nanomedicine-enabled topical treatments for dermatological conditions, including antifungal sprays BB2603 for onychomycosis and BB1202 for tinea pedis that enhance drug penetration with lower doses, and BB1511 cream for atopic dermatitis to support skin barrier and reduce inflammation; also conducts clinical trials to test safety and efficacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Blueberry Therapeutics company profile →
2C Tech
HQ: United States
Website
- Description: Provider of quantum dot-based nanotechnology for retinal degenerative diseases, delivering photovoltaic stimulation to the retina via intravitreal injection to activate photoreceptors, preserve or enhance vision, and potentially treat Retinitis Pigmentosa and Macular Degeneration, with neuroprotective effects on neuro-retinal cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 2C Tech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for California Nanotechnologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to California Nanotechnologies
2.2 - Growth funds investing in similar companies to California Nanotechnologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for California Nanotechnologies
4.2 - Public trading comparable groups for California Nanotechnologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →